Technical Analysis for NMRD - Nemaura Medical Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Crossed Above 50 DMA | Bullish | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| BB Squeeze Ended | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | 33.33% |
| Alert | Time |
|---|---|
| Gap Down Closed | about 9 hours ago |
| Reversed from Down | about 9 hours ago |
| Gapped Down (Full) | about 9 hours ago |
| Gap Up Closed | about 9 hours ago |
| Outside Day | about 9 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 08/12/2024
Nemaura Medical Inc. Description
Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Diabetes Medical Device Glucose Endocrine System Blood Test Wireless Devices Diabetes Mellitus Medical Monitoring Blood Glucose Monitoring Endocrinology Type I Diabetes Blood Sugar Level Continuous Glucose Monitor Type II Diabetes
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.25 |
| 52 Week Low | 0.0292 |
| Average Volume | 41,356 |
| 200-Day Moving Average | 0.16 |
| 50-Day Moving Average | 0.05 |
| 20-Day Moving Average | 0.05 |
| 10-Day Moving Average | 0.05 |
| Average True Range | 0.01 |
| RSI (14) | 62.96 |
| ADX | 34.25 |
| +DI | 43.29 |
| -DI | 10.37 |
| Chandelier Exit (Long, 3 ATRs) | 0.04 |
| Chandelier Exit (Short, 3 ATRs) | 0.06 |
| Upper Bollinger Bands | 0.06 |
| Lower Bollinger Band | 0.04 |
| Percent B (%b) | 1.28 |
| BandWidth | 32.64 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0013 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.06 | ||||
| Resistance 3 (R3) | 0.06 | 0.06 | 0.06 | ||
| Resistance 2 (R2) | 0.06 | 0.06 | 0.06 | 0.06 | |
| Resistance 1 (R1) | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Pivot Point | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Support 1 (S1) | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Support 2 (S2) | 0.06 | 0.06 | 0.06 | 0.06 | |
| Support 3 (S3) | 0.06 | 0.06 | 0.06 | ||
| Support 4 (S4) | 0.06 |
